Presentations:
- Prospective validation of end of treatment ctDNA-MRD by PhasED-Seq in DLBCL patients from a national trial
- Presenter: Steven Wang, MD, PhD (Amsterdam UMC)
- Session: Oral Abstract Session – Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
- Time: Friday, May 30 | 2:45 – 5:45 p.m. CDT
- Location: Room S100a or live stream for virtual attendees
- Abstract number: 7000
Posters:
- “Sequencing-guided chemotherapy optimization using real-time evaluation in newly diagnosed DLBCL with circulating tumor DNA: SHORTEN-ctDNA” (NCT06693830) Presenter: Stephanie Meek, Ph.D. (Foresight) in collaboration with Columbia University
Type: Poster #272a
Session: Poster Session – Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Date/Time: Sunday, June 1 | 9:00 a.m. – 12:00 p.m. CT | Poster Hall A - “ALPHA3: A pivotal phase 2 study of first-line (1L) consolidation with cemacabtagene ansegedleucel (cema-cel) in patients (pts) with large B-cell lymphoma (LBCL) and minimal residual disease (MRD) after response to standard therapy”
Sponsor: Allogene Therapeutics
Presenter: Jason Westin, M.D., M.S., FACP (The University of Texas MD Anderson Cancer Center)
Type: Poster #267a
Session: Poster Session – Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Date/Time: Sunday, June 1 | 9:00 a.m. – 12:00 p.m. CT | Poster Hall A - “Safety and Efficacy of AZD0486, a CD19xCD3 T-cell Engager, in Relapsed or Refractory Diffuse Large B-cell Lymphoma” (NCT04594642)
Sponsor: AstraZeneca
Presenter: Tae Min Kim, M.D. (Seoul National University Hospital)
Type: Poster #229
Session: Poster Session – Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Date/Time: Sunday, June 1 | 9:00 a.m. – 12:00 p.m. CT | Poster Hall A - “Circulating tumor DNA assessment in patients with early-stage classical Hodgkin lymphoma treated with combination of brentuximab vedotin and nivolumab” (NCT03646123)
Sponsor: Pfizer
Presenter: Ryan Lynch, M.D. (Fred Hutchinson Cancer Center)
Type: Poster #223
Session: Poster Session – Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Date/Time: Sunday, June 1 | 9:00 a.m. – 12:00 p.m. CT | Poster Hall A